A Randomized Controlled Trial Using the Health TAPESTRY Approach to Care for Older Adults (HealthTAPESTRY)

January 2, 2018 updated by: McMaster University

Health Teams Advancing Patient Experience: Strengthening Quality (TAPESTRY): A Randomized Controlled Trial Using the Health TAPESTRY Approach to Care for Older Adults

Health TAPESTRY is a delayed intervention pragmatic randomized control trial promoting interprofessional team collaboration, facilitating connection to the community through system navigation and trained community volunteers, enhancing communication and improving care through the use of technology to better understand and assist older adult patients in achieving their health goals and to enable them to have optimal aging.

Study Overview

Status

Completed

Conditions

Detailed Description

The overarching aim of the integrated multicomponent Health TAPESTRY approach is to promote optimal aging. Optimal aging within the Health TAPESTRY program means supporting people to move through life with good health in the best possible way: Being Alive Well. Health TAPESTRY is a health and social care approach that centres on meeting a person's health goals with the support of technology, trained community volunteers, an interprofessional team, system navigation, and better links between primary care and community organizations. The Health TAPESTRY intervention takes a complex, multilevel approach to integration, from both system level and individual level perspectives. The Health TAPESTRY program will provide processes and tools to activate and support individuals to access and use the broad range of available primary health care, social and community services to achieve their personal health goals and strategies to better integrate care at the system level. More specifically Health TAPESTRY will promote optimal aging:

  • through intentional, proactive conversations about a person's life, health and care goals within the primary healthcare setting;
  • through improved connections between inter-professional primary care teams, community service providers and informal caregivers;
  • by training volunteers to serve as a link between the primary care team and a person in their home;
  • by using technology from the home to link directly with the primary health care team which includes
  • the tablet-based Health TAPESTRY app for volunteers to use;
  • the Personal Health Record (PHR) and
  • innovative resources (i.e. Optimal Aging Portal).

It is anticipated that together these will enable transformation of how primary healthcare and interprofessional teams provide care to older adults in a manner that provides value for resources used and meets needs and goals of older adults.

Study Type

Interventional

Enrollment (Actual)

316

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada
        • McMaster Family Practice
      • Hamilton, Ontario, Canada
        • Stonechurch Family Health Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Any community-dwelling patient of McMaster Family Health Team over the age of 70

Exclusion Criteria:

  • Patient is palliative or receiving end-of-life care
  • Patient is deceased
  • Has explicitly stated that they do not want to be part of a research project
  • Patient resides in long-term care
  • Patient has indicated that they do not want to receive a home visit from trained community volunteers.
  • Patient or family member does not speak English
  • Patient will be out of the country for more than 50% of trial duration

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patient Group 1
This patient group will begin receiving the Health TAPESTRY intervention from time zero.
The patient will receive in-home visits from trained volunteers to assess overall health and wellness and discover any health goals patient might have. This information will be electronically communicated back to interprofessional healthcare team and used to create informed care plan, link to relevant community services and allow the patient to age optimally.
Active Comparator: Patient Group 2
Using a step-wedge approach, this patient group will receive the intervention after a six month waiting period where they will be used as a comparable group. In the first six months, they will receive usual care.
While waiting for the Health TAPESTRY intervention, the control group will receive usual care from their healthcare providers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Progress attaining health goals
Time Frame: 12 months
The participant will identify up to 5 areas of health that will serve as the basis for Goal Attainment Scale(GAS) measurement and will assign subjective weights using a scale of 1 to 9 (higher scores indicating greater importance). An indicator for each goal is selected and used to indicate progress in meeting the goal. The expected outcomes for each problem area will be identified. These outcomes will be standardized and as descriptive, objective and observable as possible. The indicators will be applied to the intervention group and control group in the same manner. Participants will be followed up at the end of 6 months by an independent and blinded assessor for the purpose of study comparison to evaluate the patient's level of goal attainment for each priority problem area that has a goal attainment scale constructed for it although participants in the intervention group may have follow occur more frequently as the information about goals is transmitted to the health care team
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life measures (2 tools)
Time Frame: 12 months
1)The EuroQol-5 Demensop-5 Level (EQ-5D-5L) is comprised of six questions investigating patients' present health status. The last question requires patients to rate one's own current health status on a scale from 0-100, 0 being worst and 100 being the best; and 2)Veterans Rand-12 (VR-12) It's a 9 item survey that focuses mainly on physical and emotional health. The survey was developed at RAND Corporation with the support of US Department of Veterans Affairs. Both of these tools are under consideration by the Canadian Institute of Health Research (CIHR) led community based primary healthcare indicators group and the proposed TAPESTRY study offers the opportunity to compare the two tools.
12 months
Self-efficacy Scale
Time Frame: 12 months
The scale measures the ability and confidence of patient to self-manage their own health. The scale comprises of 6 items and each item is responded on a 10-point Likert scale with 0 indicates not at all confident and 10 denotes totally confident.
12 months
Optimal aging
Time Frame: 12 months
Single question, "In terms of your own healthy aging, would you say it is excellent, very good, good, fair, or poor?" Ratings become a 5-point scale ranging from 1 to 5. A similar question has been used in the Canadian Longitudinal Study on Aging.
12 months
Duke Social Support Index
Time Frame: 12 months
This validated scale is comprised of 11 questions. The first seven questions measure satisfaction with social support and the latter five questions assess social networking. Satisfaction score range from 6-18 whereas networking scores ranges from 4-12. The scale facilitates understanding patients' relationships with friends/family and whoever supports them. Those individuals who score less than 10 on the satisfaction scale are considered at risk.
12 months
Comprehensiveness
Time Frame: 12 months
Perceived clinic comprehensives regarding patient healthcare needs will be assessed via CIHR common indicator (comprehensiveness domain). Participants respond to 4 questions using a 4-point scale ("not at all" to "definitely"), with an additional option of "I haven't needed such support.
12 months
Patient Empowerment
Time Frame: 12 months
The extent to which participants feel in control with regard to healthcare is measure via CIHR common indicator (patient empowerment domain). Participants respond to 5 questions using a 4-point scale ("not at all" to "definitely").
12 months
Patient Centredness
Time Frame: 12 months
The extent to which participants feel their healthcare team addresses what matters to them will be assessed via CIHR common indicator (Patient-Centredness domain). Participants respond to 6 questions using a 4-point scale ("not at all" to "completely").
12 months
Access
Time Frame: 12 months
Patient access to services will be assessed via CIHR common indicators project: Access subdomain.
12 months
Satisfaction with Care
Time Frame: 12 months
This is a one item scale that about satisfaction with primary care received. Participants are asked to rate their level of satisfaction from 1 ("not at all satisfied") to 10 ("completely satisfied").
12 months
Hospitalizations for Ambulatory Care Sensitive Conditions (ACSC) for Chronic Disease
Time Frame: 12 months
An indirect measure of access to primary care is seen for example, in increased for diagnoses that can be effectively managed outside hospital (ambulatory care sensitive conditions; ACSCs). ACSCs such as chronic obstructive pulmonary diseases, asthma, diabetes, hypertension, angina and others), have rates of 387 per 100,000 for those aged 75 to 84 years compared to 2240 per 100,000 for those 85 years or older. Hospitalizations for Adverse Events will also be calculated.
12 months
Caregiver Strain Index
Time Frame: 12 months
For those participant who answer "yes" to being a caregiver, the 4-item Zarit screen will be administered in addition to a description of the context of their caregiving will be given. For this screen, participants answer 4 questions using a 5-point scale from "never" to "always".
12 months
Cost-effectiveness
Time Frame: 12 months
Program costs: Will be measured using micro costing techniques where a healthcare cost and Resource utilization form has been pilot tested to record resources used during the implementation of the TAPESTRY program. This resource use information will be combined with unit prices for each resource and summed across all resources to estimate the total cost of the program. Maintaining and updating infrastructure costs will be included. Healthcare resource use and cost: Will be obtained from the patient questionnaire that will assess cost and resources involved in providing healthcare for older adults.
12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patients' Satisfaction with Volunteers
Time Frame: 12 months
Patients will be asked to rate their level of satisfaction with volunteer visits.
12 months
Team Functioning
Time Frame: 12 months
An adapted version of the Organizational Readiness for Change Assessment (ORCA) will be used to measure team functioning. This questionnaire includes 18 questions to assess evidence, context, and facilitation and to give a general sense of healthcare professionals' perceptions of the clinic's organizational readiness for change as it relates to the uptake of TAPESTRY
12 months
Volunteers' Self-efficacy
Time Frame: 12 months
Volunteers will be asked to rate their confidence in performing 3 tasks related to a volunteer visit for each visit they complete.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: David Price, MD, McMaster University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2014

Primary Completion (Actual)

November 1, 2016

Study Completion (Actual)

November 1, 2016

Study Registration Dates

First Submitted

November 3, 2014

First Submitted That Met QC Criteria

November 3, 2014

First Posted (Estimate)

November 5, 2014

Study Record Updates

Last Update Posted (Actual)

January 3, 2018

Last Update Submitted That Met QC Criteria

January 2, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 14-726

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Health TAPESTRY Intervention

3
Subscribe